Tags

Type your tag names separated by a space and hit enter

COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
Am J Crit Care. 2020 11 01; 29(6):489-492.AJ

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Halm MA
Margo A. Halm is associate chief nurse executive, nursing research and evidence-based practice, VA Portland HealthCare System, Portland, Oregon.

MeSH

AntimalarialsBetacoronavirusCOVID-19ChloroquineCoronavirus InfectionsHeart DiseasesHospital MortalityHumansHydroxychloroquinePandemicsPneumonia, ViralSARS-CoV-2

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32839815

Citation

Halm, Margo A.. "COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits." American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses, vol. 29, no. 6, 2020, pp. 489-492.
Halm MA. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits. Am J Crit Care. 2020;29(6):489-492.
Halm, M. A. (2020). COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits. American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses, 29(6), 489-492. https://doi.org/10.4037/ajcc2020694
Halm MA. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits. Am J Crit Care. 2020 11 1;29(6):489-492. PubMed PMID: 32839815.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits. A1 - Halm,Margo A, PY - 2020/8/26/pubmed PY - 2020/11/25/medline PY - 2020/8/26/entrez SP - 489 EP - 492 JF - American journal of critical care : an official publication, American Association of Critical-Care Nurses JO - Am J Crit Care VL - 29 IS - 6 SN - 1937-710X UR - https://www.unboundmedicine.com/medline/citation/32839815/COVID_19_and_Antimalarial_Drugs:_Harms_Outweigh_Benefits_ L2 - https://aacnjournals.org/ajcconline/article-lookup/doi/10.4037/ajcc2020694 DB - PRIME DP - Unbound Medicine ER -